News

Article

Maui Derm NP + PA 2024 | Fall Conference Preview

Author(s):

This is an overview of our upcoming Maui Derm NP+PA Fall 2024 Program conference coverage.

Maui Derm NP + PA 2024 | Fall Conference Preview

The Maui Derm NP+PA Fall 2024 conference begins September 15. It was created to expand upon the excellent, high-quality dermatology education available for Nurse Practitioners and Physician Assistants. A series of 3 specialized meetings were created specifically for NPs and PAs in the field of dermatology, and this conference is 1 example.

Maui Derm NP+PA Fall is a 4-day conference, with in-person presentations at the Gaylord Opryland from September 15 - 18, 2024. The meeting’s website also notes that it may provides a variety of networking opportunities for PAs and NPs, with social functions, exhibits, and product theater luncheons.

The HCPLive editorial team will be covering Maui Derm NP+PA Fall 2024, attending alongside prominent educators and leaders from both NP and PA groups. The conference’s curriculum provides updates on key topics in dermatology, with the content carefully structured with the aim of reinforcing essential concepts without repeating material.

Notable Sessions

The 2024 conference may allow greater awareness of the significant advances made in the field related to the diagnosis, treatment, and management of both cosmetic and medical dermatologic conditions. The meeting’s line-up is full of expert speakers and the latest updates in dermatology.

Interviews with HCPLive onsite are slated for a variety of featured guests, some of which include the following:

  • James Del Rosso, DO, FAOCD, research director of JDR Dermatology Research and president of the American Acne and Rosacea Society.
  • Donna Culton, MD, PhD, professor of dermatology at the University of North Carolina, Chapel Hill, North Carolina.
  • Raj Chovatiya, MD, PhD, clinical associate professor of medicine at the Rosalind Franklin University Chicago Medical School.
  • Matthew Zirwas, MD, director of the clinical trials and dermatitis center at Dermatologists of Greater Columbus.

These experts and others are slated to highlight some of the aforementioned developments and updates in the field of dermatology treatment and management research. Some examples of presentations attendees may wish to view include the following:

New Products and New Therapies

Ted Rosen, MD, and George Martin, MD, highlight some of the newest drugs and therapies in dermatology, discussing how NPs and PAs may be using them in 2024 and beyond.

Psoriasis and Psoriatic Arthritis Update 2024

Some of the faculty members will speak on what is new in psoriasis and psoriatic arthritis within the last year, highlighting new drugs and therapies. The event will also feature a series of challenging case scenarios in psoriatic disease, with attendees being asked to weigh in on their selection of therapies on a survey app.

Hidradenitis Suppuritiva Update 2024

Raj Chovatiya, MD, PhD, speaks about HS, one of the most challenging clinical situations in the dermatology space. Chovatiya highlights a combination of medical and surgical management strategies as well as the introduction of new treatments and how they will be implemented.

Blistering Diseases: What’s the Diagnosis

Donna Culton, MD, presents a series of blistering disease cases which may challenge attendees’ diagnostic and therapeutic acumen. Following the presentation of case scenarios, those attending will be asked to weigh in on their diagnosis and therapeutic choices on the survey app.

Pediatric Dermatology Update 2024

Three pediatric dermatologists will highlight the latest in diagnostic and therapeutic approaches to a variety of diagnostic and therapeutic scenarios. These scenarios will involve neonates and children.

Follow our latest conference coverage here to stay informed about onsite interviews with dermatologists, the contents of these presentations, and the latest developments in the field that are covered.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.